Canon Medical Systems USA is set to introduce the Aquilion Exceed LB CT system with the latest simulation capabilities for radiation oncology.

The system, which yet to obtain 510(k) market clearance, is developed to provide radiation oncologists with fast radiation oncology workflows.

It features 90cm large bore opening, 90cm field-of-view, as well as 4cm reconstruction and wide detector coverage.

Additionally, Aquilion provides sharp, clear and distinct images, leveraging Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology.

Due to its extended capabilities, the system is positioned for shared services to facilitate treatment follow-up and interventional procedures.

Canon Medical Systems USA CT Business Unit managing director Erin Angel said: “Accurate simulation across even the most challenging treatment plans is imperative during radiation therapy planning.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“At Canon Medical, we deliver solutions that meet providers’ needs but also push the boundaries of traditional simulation.

“With the Aquilion Exceed LB, we brought deep learning reconstruction to the CT simulation space. This will revolutionise care for cancer patients and give the radiation oncology team the confidence and precision they need for accurate planning across patients.”

Approximately 1.8 million new cancer cases are estimated to be diagnosed in the US this year alone.

In February, Canon Medical secured 510(k) clearance from the Food and Drug Administration (FDA) for the Aquilion ONE / PRISM Edition, which enables Deep Learning Spectral capabilities for more routine spectral imaging.

In 2018, the company introduced a deep convolutional neural network image reconstruction technology of CT scans.